MMJ BioPharma计划就违反宪法的大麻研究审批延误对缉毒署提出紧急诉讼。 MMJ BioPharma plans emergency lawsuit against DEA over unconstitutional cannabis research approval delays.

MMJ生物药厂计划对缉毒局提出紧急诉讼,辩称其行政听证程序违宪,侵犯了公司的权利。 MMJ BioPharma Cultivation plans to file an emergency lawsuit against the DEA, arguing its administrative hearing process is unconstitutional and violates the company's rights. MMJ自2018年以来寻求缉毒局批准对亨廷顿和MS等疾病进行大麻研究,声称该程序超过法定时限,违宪。 MMJ, seeking DEA approval since 2018 for cannabis research on diseases like Huntington's and MS, claims the process exceeds legal time limits and is unconstitutional. 该诉讼旨在阻止缉毒局的听证,并宣布其程序非法。 The lawsuit seeks to halt the DEA's hearing and declare its process unlawful.